VPDiagnostics: Atherosclerosis Characterization for Effective Stroke Prevention

OUR MISSION

We develop evidence-based imaging solutions to non-invasively diagnose high-risk atherosclerotic plaque before rupture and to enable effective stroke preventive treatments.

VPDiagnostics currently offers the FDA cleared software product: MRI-PlaqueView^TM. Characterization of plaque from vessel wall imaging by MRI-PlaqueView^TM can assist clinicians in making management decisions based upon scientific literature, and planning for the most suitable treatment. It also enables timely and quantitative detection of disease progression in medical research and drug development.

MRI of vessel wall for plaque characterization has recently been included in American College of Radiology (ACR) Appropriateness Criteria for MRA neck procedures. Furthermore, VPDiagnostics is leading an NIH-sponsored multi-center prospective clinical trial to evaluate a new diagnostic utility for use with MRI-PlaqueView^TM that will enable the prediction of future risk of stroke and related neurological complications based on plaque characteristics.

Accurate Assessment of Atherosclerosis for Effective Stroke Prevention